The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Microsatellite Instability in Colorectal Cancer-the Stable Evidence
Open accessAbstract
Microsatellite instability (MSI) is the molecular fingerprint of a deficient mismatch repair system. Approximately 15% of colorectal cancers (CRC) display MSI owing either to epigenetic silencing of MLH1 or a germline mutation in one of the mismatch repair genes MLH1, MSH2, MSH6 or PMS2. Methods to detect MSI are well established and routinely incorporated into clinical practice. A clinical and molecular profile of MSI tumors has been described, leading to the concept of an MSI phenotype in CRC. Studies have confirmed that MSI tumors have a better prognosis than microsatellite stable CRC, but MSI cancers do not necessarily have the same response to the chemotherapeutic strategies used to treat microsatellite stable tumors. Specifically, stage II MSI tumors might not benefit from 5-fluorouracil-based adjuvant chemotherapy regimens. New data suggest possible advantages of irinotecan-based regimens, but these findings require further clarification. Characterization of the molecular basis of MSI in CRC is underway and initial results show that mutations in genes encoding kinases and candidate genes with microsatellite tracts are over-represented in MSI tumors. Transcriptome expression profiles of MSI tumors and systems biology approaches are providing the opportunity to develop targeted therapeutics for MSI CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tumors with MSI tend to have a better prognosis but respond differently to standard chemotherapeutic regimens [75].”
From Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer (2024) · cites this paper as [75]
In the citing paper
“Approximately 15% of CRC tumors are characterized by microsatellite instability (MSI) [75].”
From Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer (2024) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature reviews. Cancer · doi:10.1038/nrc839 · Cited by 6,155
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A. F., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,448
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Rüschoff, J., Fishel, R. A., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,181
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G. D., & Schaid, D. J. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,131
Systematic review and meta-analysis
Gillies, A. (2019) · CRC Press eBooks · doi:10.1201/9781315377315-19 · Cited by 2,876
Cited by
Sorted by citations
Items 601–700 of 1,000
Molecular Approach to Colorectal Carcinoma
Beech, C. M., & Hechtman, J. F. (2024) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2023.08.011 · Cited by 7
Mane, A., & Basade, M. (2020) · Indian Journal of Cancer · doi:10.4103/ijc.ijc_507_19 · Cited by 7
Hypermutated phenotype in gliosarcoma of the spinal cord
Hong, C. S., Kuzmik, G. A., Kundishora, A. J., Elsamadicy, A. A., Koo, A. B., McGuone, D., Blondin, N. A., DiLuna, M. L., & Erson-Omay, Z. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00143-w · Cited by 7
Tran, C. G., Goffredo, P., Mott, S. L., Suraju, M. O., Kohn, J. F., Mishra, A., Vauthey, J., & Hassan, I. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-14443-x · Cited by 7
Babaei, H., Zeinalian, M., Emami, M. H., Hashemzadeh, M., Farahani, N., & Salehi, R. (2017) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2016.0091 · Cited by 7
Finding the hot spot: identifying immune sensitive gastrointestinal tumors
de Souza, A. L. P. B. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.12.11 · Cited by 7
Xu, X., Tang, Y., Zhu, J., & Luo, J. (2022) · Journal of Oncology · doi:10.1155/2022/5860671 · Cited by 7
Bhattarai, M., Juhari, W. K. W., Lama, R., Pun, C. B., Yusof, W., Rahman, W. F. W. A., Zakaria, A. D., Noordin, K. B. A. A., Shrestha, T. R., & Zilfalil, B. A. (2020) · Medical Journal of Indonesia · doi:10.13181/mji.oa.203633 · Cited by 6
Gene Expression Profile Reveals a Prognostic Signature of Non–MSI-H/pMMR Colorectal Cancer
Liu, Z., Xu, H., Ge, X., Weng, S., Dang, Q., & Han, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.790214 · Cited by 6
Hashmi, A. A., Bukhari, U., Rizwan, R., Faisal, F., Kumar, R., Malik, U. A., Zia, S., Khan, A. R., Sham, S., & Irfan, M. (2023) · Cureus · doi:10.7759/cureus.42781 · Cited by 6
Holubeková, V., Loderer, D., Grendár, M., Mikolajčík, P., Kolková, Z., Turyova, E., Kúdelová, E., Kalman, M., Marcinek, J., Miklušica, J., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1206482 · Cited by 7
Yang, K., Ma, Y., Chen, W., Liu, L., Yang, Z., He, C., Zheng, N., Liu, X., Cheng, X., Song, J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-59154-9 · Cited by 6
Microsatellite instability in gastric cancer: molecular features and clinical implications
Zhang, Z., Liu, Z., Gu, Y., Luo, R., Tang, Z., Sun, Y., & Wang, X. (2024) · Clinical Cancer Bulletin · doi:10.1007/s44272-024-00017-9 · Cited by 6
The Role of CAF‐derived Vitronectin in Promoting Colorectal Cancer Progression and Immunosuppression
Yu, J., Xiu, M., Yu, S., Chen, Z., Li, Y., & Gao, Y. (2025) · Advanced Science · doi:10.1002/advs.202505769 · Cited by 6
HGUE-C-1 is an atypical and novel colon carcinoma cell line
Grasso, S., Martínez-Lacaci, I., Barberá, V. M., Castillejo, A., Soto, J. L., Gallego-Plazas, J., López, N., García-Morales, P., Mata‐Balaguer, T., Ferragut, J. A., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1183-3 · Cited by 6
Coté, M. L., Kam, A. E., Chang, C. Y.-Y., Raskin, L., Reding, K. W., Cho, K. R., Gruber, S. B., & Ali‐Fehmi, R. (2011) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e318224329e · Cited by 6
Self-citationCAT25 defines microsatellite instability in colorectal cancer by high-resolution melting PCR
Sánchez, A. V., Juaneda, I., Eynard, H., Basquiera, A. L., Palazzo, E., Calafat, P., Palla, V., Romagnoli, P. A., & Alvarellos, T. R. (2020) · British Journal of Biomedical Science · doi:10.1080/09674845.2020.1730625 · Cited by 6
Mou, W., Zhu, L., Yang, T., Lin, A., Lyu, Q., Guo, L., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02651-6 · Cited by 6
Cao, F., Hu, J., Yuan, H., Cao, P., Cheng, Y., & Wang, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.963565 · Cited by 6
Sun, Z., Li, G., Shang, D., Zhang, J., Ai, L., & Liu, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.988303 · Cited by 6
Riok1, A Novel Potential Target in MSI-High p53 Mutant Colorectal Cancer Cells
Shechter, S., Bar, S. Y., Khattib, H., Gage, M. J., & Avni, D. (2023) · Molecules · doi:10.3390/molecules28114452 · Cited by 6
A comprehensively prognostic and immunological analysis of PARP11 in pan-cancer
Wang, S., Zhang, M., Li, T., Chen, X., Wu, Q., Tian, D., Granot, Z., Xu, H., Hao, J., & Zhang, H. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae030 · Cited by 6
Mizoguchi, M., Hata, N., Suzuki, S. O., Fujioka, Y., Murata, H., Amano, T., Nakamizo, A., Yoshimoto, K., Iwaki, T., & Sasaki, T. (2013) · Neuropathology · doi:10.1111/neup.12029 · Cited by 6
Kwan, A. K., Um, C. Y., Rutherford, R. E., Seabrook, M. E., Barry, E. L., Fedirko, V., Baron, J. A., & Bostick, R. M. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22945 · Cited by 6
Nojadeh, J. N., Hashemzadeh, S., Kafil, H. S., Sharif, S. B., Eftekharsadat, A., Ghasemnejad, T., Ghojazadeh, M., & Sakhinia, E. (2018) · EXCLI journal · doi:10.17179/excli2018-1455 · Cited by 6
Fujii, C., Mochizuki, A., Dreike, S., & Jeter, J. (2025) · Cancers · doi:10.3390/cancers17040659 · Cited by 5
Shi, L., Wang, H., Sun, Y., Xu, N., Pei, A., & Zhang, N. (2025) · Discover Oncology · doi:10.1007/s12672-025-02055-8 · Cited by 5
Ma, X., Zhu, Q., Wu, Z., & Han, W. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090712 · Cited by 5
Mismatch repair deficiency and microsatellite instability in adrenocortical carcinoma
Altieri, B., Kircher, S., Herterich, S., Jahn, A., Teleanu, M.-V., Lippert, J., Landwehr, L.-S., Kimpel, O., Reuter, M., Remde, H., et al. (2026) · ESMO Open · doi:10.1016/j.esmoop.2025.106030 · Cited by 5
Gao, R., Yang, Z., Yuan, X., Wang, Y., Xia, Y., Zhang, Y., Zheng, B., Gong, Y., Yue, Y., Tu, Y., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71558-x · Cited by 6
Pashkov, D. V., Venina, A. R., Иванцов, А. О., Yanus, G. A., Раскин, Г. А., Имянитов, Е. Н., Kubrina, S. E., Mikushina, A. D., Manikhas, G. M., Ponomareva, E. V., et al. (2020) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2020-19-1-31-39 · Cited by 5
Correlation between mismatch repair statuses and the prognosis of stage I–IV colorectal cancer
Tong, G., Zhang, G., Hu, Y. P., Xu, X., & Wang, Y. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1278398 · Cited by 5
Pan-Cancer Molecular Biomarkers: Practical Considerations for the Surgical Pathologist
Jafari, P., Forrest, M. E., Segal, J. P., Wang, P., & Tjota, M. Y. (2025) · Modern Pathology · doi:10.1016/j.modpat.2025.100752 · Cited by 5
Evrard, C., Rochelle, T., Martel, M., Achkar, A. A., Ferru, A., Randrian, V., Karayan, L., & Tougeron, D. (2025) · Laboratory Investigation · doi:10.1016/j.labinv.2025.104176 · Cited by 5
Tu, H., Ahearn, T. U., Daniel, C. R., Gonzalez‐Feliciano, A. G., Seabrook, M. E., & Bostick, R. M. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22152 · Cited by 5
Schaeybroeck, S. V., Lawler, M., Johnston, B. T., Salto‐Tellez, M., Lee, J., Loughlin, P., Wilson, R. H., & Johnston, P. G. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00077-1 · Cited by 5
Meng, Q., Li, C.-X., & Long, D. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s318278 · Cited by 5
Molecular Approach to Colorectal Carcinoma
Beech, C. M., & Hechtman, J. F. (2021) · Surgical pathology clinics · doi:10.1016/j.path.2021.05.007 · Cited by 5
Lin, Z., Wu, Y., Xiao, X., Zhang, X., Wan, J., Zheng, T., Chen, H., Liu, T., & Tang, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.938510 · Cited by 5
Sfakianaki, M., Tzardi, M. N., Tsantaki, K., Koutoulaki, C., Messaritakis, I., Datseri, G., Moustou, E., Mavroudis, D., & Souglakos, J. (2023) · Cancers · doi:10.3390/cancers15020353 · Cited by 5
Goshima, T., Ieguchi, K., Onishi, N., Shimizu, T., Takayanagi, D., WATANABE, M., Fujimoto, Y., Ohkuma, R., Suzuki, R., Tsurui, T., et al. (2023) · Anticancer Research · doi:10.21873/anticanres.16784 · Cited by 5
Integrated analysis of FHIT gene alterations in cancer
Simón-Carrasco, L., Pietrini, E., & Lopez-Contreras, A. J. (2024) · Cell Cycle · doi:10.1080/15384101.2024.2304509 · Cited by 5
Clinicopathological outcomes of microsatellite instability in colorectal cancer
Gülşen, T., Ergenç, M., Şenol, Z., Emi̇rzeoglu, L., & Güleç, B. (2022) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1560_22 · Cited by 5
Mao, C., Li, S., Che, J., Liu, D., Mao, X., & Rao, H. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107592 · Cited by 5
Rectal Cancer: Exploring Predictive Biomarkers Through Molecular Pathways Involved in Carcinogenesis
Martins, S., Veiga, P., Tralhão, J. G., Carreira, I. M., & Ribeiro, I. P. (2024) · Biology · doi:10.3390/biology13121007 · Cited by 5
Yang, S., Bai, Z., Zhang, F., Cui, W., Bu, P., Bai, W., & Xi, Y. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03643-2 · Cited by 5
Molecular classification of esophagogastric junction carcinoma correlated with prognosis
Zou, L., Wu, Y., Ma, K., Fan, Y., Dong, D., Geng, N., & Li, E. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s145912 · Cited by 5
Lee, P. J., McNulty, S. N., Duncavage, E. J., Heusel, J. W., & Hagemann, I. S. (2017) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000459 · Cited by 5
Genomic clustering of fitness‐affecting mutations favors the evolution of chromosomal instability
Raynes, Y., & Weinreich, D. M. (2018) · Evolutionary Applications · doi:10.1111/eva.12717 · Cited by 5
Arabsorkhi, Z., Sadeghi, H., Gharib, E., Rejali, L., Asadzadeh‐Aghdaei, H., & Mojarad, E. N. (2021) · Genes & Genetic Systems · doi:10.1266/ggs.21-00026 · Cited by 5
Lungulescu, C., Croitoru, V. M., Volovăț, S. R., Cazacu, I. M., Turcu-Ştiolică, A., Gheonea, D. I., Sur, D. G., & Lungulescu, C. V. (2021) · Medicina · doi:10.3390/medicina57080847 · Cited by 5
SSCS: A Stage Supervised Subtyping System for Colorectal Cancer
Zhao, L., & Pan, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9121815 · Cited by 5
Systematic pan-cancer analysis identifies cGAS as an immunological and prognostic biomarker
Chen, P., Yang, X., Wang, P., He, H., Chen, Y., Yu, L., Fang, H., Wang, F., & Huang, Z. (2023) · Annals of Translational Medicine · doi:10.21037/atm-22-6318 · Cited by 5
Ya, X. I. A. O., Wang, S., Ren, L. I. N. G., & Song, Y. (2023) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2022-0569 · Cited by 5
McKenzie, R., Scott, R. J., Otton, G. R., & Scurry, J. (2015) · Pathology · doi:10.1016/j.pathol.2015.11.003 · Cited by 5
Gönen, M. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1311-3 · Cited by 5
Shirazi, M., & Sepulveda, A. R. (2018) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2018.07.010 · Cited by 5
Yu, Y., Ying, J., Zhang, W., Li, W., Sun, Y., Yang, L., Cui, C., Zeng, Y., & Zhou, A. (2019) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.13130 · Cited by 5
Pirini, F., Pasini, L., Tedaldi, G., Scarpi, E., Marisi, G., Molinari, C., Calistri, D., Passardi, A., & Ulivi, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103532 · Cited by 5
Tang, Y., Lin, C., & Lai, C. (2021) · Genes · doi:10.3390/genes12101593 · Cited by 5
Universal Genetic Testing for Younger Patients With Colorectal Cancer
Vilar, E., & Stoffel, E. M. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5193 · Cited by 5
Self-citationA Model of Selective Advantage for the Efficient Inference of Cancer Clonal EvolutionPreprint
Ramazzotti, D. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1602.07614 · Cited by 5
Wei, H., Zhang, X., Zhou, Z., Xie, J., Han, W., & Dong, X. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1580195 · Cited by 4
Colombo, A., Porretto, C. M., Gebbia, V., Sambataro, D., Scandurra, G., & Valerio, M. R. (2024) · In Vivo · doi:10.21873/invivo.13802 · Cited by 4
Werner helicase as a therapeutic target in mismatch repair deficient colorectal cancer
Hao, S., Liu, Z., Lenz, H., Yu, J., & Zhang, L. (2025) · DNA repair · doi:10.1016/j.dnarep.2025.103831 · Cited by 5
Multicancer analyses of short tandem repeat variations reveal shared gene regulatory mechanisms
Xia, F., Verbiest, M. A., Lundström, O., Sonay, T. B., Baudis, M., & Anisimova, M. O. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf219 · Cited by 4
Wild, H., Liebmann, A., Maennel, L., Maschke, L., Block, A., Kager, L., Kontny, U., Agaimy, A., Kuhlen, M., Redlich, A., et al. (2025) · Pediatric Blood & Cancer · doi:10.1002/pbc.31830 · Cited by 4
Risk Factors of Multiple Primary Cancers Among Colorectal Cancer Survivors
Melku, M., Best, G., Winter, J. M., Thurgood, L. A., Ahmed, M. B., Kichenadasse, G., Wassie, M. M., & Symonds, E. L. (2025) · Cancers · doi:10.3390/cancers17132145 · Cited by 5
Li, Z., Ding, Z., Lian, Y., Liu, Y., Wang, L., Hu, P., Zhang, F., Luo, Y., & Qiu, H. X. (2025) · Insights into Imaging · doi:10.1186/s13244-025-02050-1 · Cited by 4
Ye, H., Liu, R., Shen, J., Yang, W., Hu, T., Liu, X., Wang, K., Gong, L., Xu, H., Zhu, J., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105979 · Cited by 4
Liu, Q., Liang, J., Gu, Y., Gao, H., Yang, D., Jiang, Y., Zhang, J., Lei, Q., & Yang, B. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114351 · Cited by 4
China Working Group on Colorectal Cancer Survey, Zhang, X., Lian, X., Gu, X., Liu, Y., Feng, C.-Y., Li, L., Xu, H., Du, J.-C., Zhao, Y., et al. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-988 · Cited by 4
Fan, X., Bai, Q., Shi, C., Xiao, Y., & Wang, X. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2257133 · Cited by 4
Rashid, M., Rashid, R., Gadewal, N. S., Carethers, J. M., Koi, M., Brim, H., & Ashktorab, H. (2024) · Neoplasia · doi:10.1016/j.neo.2024.100970 · Cited by 4
Xiaojian, Y., Zhanbo, Q., Chu, J., Wang, Z., Liu, J., Liu, J., Pan, Y., & Han, S. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05992-z · Cited by 5
Nurse night shift work and risk of gastrointestinal cancers
Guo, L., & Li, X. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1532623 · Cited by 5
TP53 and DNA-PK as potential biomarkers for enhanced efficacy of Olaparib in colorectal cancer
Kim, D. Y., Yun, H., You, J.-E., Park, Y. S., Ryu, Y. S., Koh, D., Shin, J.-S., & Jin, D.-H. (2025) · Investigational New Drugs · doi:10.1007/s10637-025-01544-5 · Cited by 4
Genetic Intratumor Heterogeneity
Alpár, D., Barber, L. J., & Gerlinger, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800206-3.00024-0 · Cited by 4
Análisis molecular del cáncer de colon esporádico
Hurtado, C., Wielandt, A. M., Zárate, A., Kronberg, U., Castro, M., Yamagiwa, K., Ito, T., Eishi, Y., Contreras, L., & López-Köstner, F. (2015) · Revista médica de Chile · doi:10.4067/s0034-98872015000300005 · Cited by 4
Microsatellite Instability in Colorectal Cancer
Parine, N. R., Varsha, R. S., & Alanazi, M. S. (2016) · InTech eBooks · doi:10.5772/65429 · Cited by 4
Cadherins down-regulation: towards a better understanding of their relevance in colorectal cancer.
Losi, L., Zanocco‐Marani, T., & Grande, A. (2020) · PubMed · doi:10.14670/hh-18-236 · Cited by 4
Xiong, K., Tao, Z., Zhang, Z., Wang, J., & Zhang, P. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.850669 · Cited by 4
Guo, Y., Yang, J., Gao, H., Tian, X., Zhang, X., & Kan, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.927635 · Cited by 4
Chen, Z., & Yam, J. W. P. (2022) · Clinical and Translational Discovery · doi:10.1002/ctd2.111 · Cited by 5
Pan-Cancer Analysis of the Roles and Driving Forces of RAB42
Zheng, M., Wang, W., Bu, Y., Liu, J., Ma, J., Wang, R., Ren, X., Lü, Z., Li, J., & Cai, J. (2022) · Biomolecules · doi:10.3390/biom13010043 · Cited by 4
Su, A., Pedraza, R., & Kennecke, H. F. (2023) · Current Oncology · doi:10.3390/curroncol30040279 · Cited by 4
NKT-Licensed In Vivo Dendritic Cell-Based Immunotherapy as Cellular Immunodrugs for Cancer Treatment
Fujii, S., & Shimizu, K. (2023) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2023048735 · Cited by 4
Zakout, Y. M.-A., & Lanza, G. (2018) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-018-0118-z · Cited by 4
The Clinical Significance of Microsatellite Instability in Precision Treatment
Huang, Z., Chen, X., Liu, C., & Cui, L. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0904-0_3 · Cited by 4
Zhang, C., Zhan, Y., Ni, K., Liu, Z., Xin, R., Han, Q., Li, G., Ping, H., Liu, Y., Zhao, X., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-10266-3 · Cited by 4
Prognostic relevance of microsatellite instability in pT3N0M0 colon cancer: a population-based study
Iachetta, F., Domati, F., Bonetti, L. R., Barresi, V., Magnani, G., Marcheselli, L., Cirilli, C., & Pedroni, M. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1285-6 · Cited by 4
Molecular Parameters for Prognostic and Predictive Assessment in Colorectal Cancer
Carrer, A., Giacca, M., & Giacca, M. (2012) · Updates in surgery/Updates in surgery series · doi:10.1007/978-88-470-2670-4_4 · Cited by 4
Pathology and Molecular Pathology of Colorectal Cancer
Poulin, E. J., Shen, J., Gierut, J. J., & Haigis, K. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-35153-7_22 · Cited by 4
Markoš, P., Brčić, I., Brčić, L., Jakić‐Razumović, J., & Pulanić, R. (2018) · Croatian Medical Journal · doi:10.3325/cmj.2018.59.100 · Cited by 4
Colon Adenocarcinoma Stage IIA—Can We Predict Relapse?
Pinto, J. C., Rosa, I., Martins, C., Marques, I. S., da Silva, J. P., Fonseca, R., Freire, J., & Pereira, A. D. (2019) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-019-00218-9 · Cited by 4
Liu, X., Yang, H., Wu, X., Huang, K., Ma, P., Jiang, P., Zheng, W., Tang, T., & Liu, D. (2019) · Oncology Letters · doi:10.3892/ol.2019.10607 · Cited by 4
Zhou, J., Liu, J., Yu, Y., Nie, H., Hong, Y., Ning, Y., Yang, C., Lai, J., Wang, H., Tang, X., et al. (2025) · Cancer Medicine · doi:10.1002/cam4.70740 · Cited by 3
Luo, Z., Wang, D., Wang, Z., Zhao, H., & Xiang, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1645412 · Cited by 3
Ren, D., Wang, Y., Chen, L., He, J., & Shen, T. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1672636 · Cited by 3
Qing, S., Ling, Y., Lai, Y., Hu, Y., Zhong, Y. H., Liu, Y., Liu, X., Fang, Y., Qian, J., Deng, H., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07993-7 · Cited by 3
Metadata
- Authors
- Vilar, E., & Gruber, S. B.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Gruber, Stephen B.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2010-02-09
- Volume
- 7
- Issue
- 3
- Pages
- 153-162
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- PMC
- PMC3427139
- OpenAlex
- W2050658928
- Cited by
- 1,063
- References
- 100
- Citations by year
- 2026: 57 · 2025: 100 · 2024: 116 · 2023: 114 · 2022: 99 · 2021: 81 · 2020: 75 · 2019: 65 · 2018: 66 · 2017: 46 · 2016: 34 · 2015: 47 · 2014: 44 · 2013: 44 · 2012: 28
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (5P30 CA 46592, 1R01CA81488, R01CA081488, P30CA046592)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- microsatellite instability, colorectal cancer, mismatch repair deficiency, prognosis, predictive biomarkers, irinotecan, kinase mutations, targeted therapy
- MeSH terms
- DNA Repair, Humans, Colorectal Neoplasms, Germ-Line Mutation, DNA Repair Enzymes, Microsatellite Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review